ELISpot Plus: Human IFN-gamma (ALP)

Lunemann, J. D., et al. (2008). EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. The Journal of experimental medicine.

Czerkinsky, C., et al. (1988). Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. Journal of immunological methods.

ranz, L. M., et al. (2016). Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature.

Sahin, U., et al. (2017). Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature.

Ott, P. A., et al. (2017). An immunogenic personal neoantigen vaccine for patients with melanoma. Nature.